A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
To investigate whether depression is a consequence of disturbed function in 5HT systems, neuroendocrine responses to infusions of the 5HT precursor L-tryptophan (LTP) were studied in patients and controls. After an overnight fast and 60 min bed rest, a solution of LTP (10 g/l) was infused intravenously to a dose of 100 mg/kg over 30 min. Circulating growth hormone (GH), prolactin (PRL), cortisol and tryptophan concentrations were followed from 60 min pre-infusion to 60 min post-infusion. GH responses were attenuated in 23 major depressives (DSM-III) compared with 22 controls and were almost absent in endogenous depressives (New-castle criteria). PRL responses were normal in depressives who had lost more than 3 kg body weight but attenuated in those who had not. GH and PRL responses did not correlate with each other. Reduced basal tryptophan concentrations and more rapid tryptophan clearance were observed in the depressives, but there were no correlations with GH or PRL responses. However, basal cortisol concentrations, which were raised in depressives with chronic psychosocial difficulties, were strongly and inversely predictive of PRL responses in depressives and controls. Blunted GH and PRL responses to LTP appear to be distinct abnormalities in depression which may relate to two processes; (1), an endogenous mechanism indicated by reduced GH responses, and (2), an impairment in 5HT systems, indicated by blunted PRL responses and perhaps caused by raised circulating cortisol or reduced tryptophan concentrations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intravenous citalopram (an SSRI) and tryptophan challenge were found reasonably consistently to evoke reduced prolactin and growth hormone responses in depressives compared with controls (Cowen and Charig, 1987;Deakin et al. 1990;Price et al., 1991, Kapitany et al., 1999).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Deakin et al. 1990
Citations
Cites
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682 · cited 1×
“Deakin a global and indirect measure of presynaptic 5HT function in brain and many studies find reduced concentrations in depressives (Sjostrom and Roos 1972; Asberg et al. 1976).”
BackgroundINCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
Stanley, M., & Mann, J. J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92590-4 · Cited by 529 · cited 1×
“Some, but not all, of these studies report increases in 5HT2 receptor binding ( Stanley and Mann 1983; Crow et al. 1984; Fertier et al. 1986).”
Backgroundde Montigny, C., & Aghajanian, G. K. (1978) · Science · doi:10.1126/science.725608 · Cited by 475
Clinical Trial of the Treatment of Depressive Illness
(1965) · BMJ · doi:10.1136/bmj.1.5439.881 · Cited by 398
CROW, T. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90100-x · Cited by 308 · cited 1×
“Some, but not all, of these studies report increases in 5HT2 receptor binding (Stanley and Mann 1983; Crow et al. 1984; Fertier et al. 1986).”
BackgroundBOURNE, H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92459-8 · Cited by 304
Heninger, G. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790150088012 · Cited by 279
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats
Kennett, G. A., Dickinson, S. L., & Curzon, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90684-5 · Cited by 253
Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
GOODWIN, F. K., POST, R. M., DUNNER, D. L., & GORDON, E. K. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.73 · Cited by 244
5-Hydroxytryptamine and punishment
TYE, N. C., EVERITT, B. J., & IVERSEN, S. D. (1977) · Nature · doi:10.1038/268741a0 · Cited by 232 · cited 1×
“It has seemed at odds with animal experiments which have implicated 5HT systems in mechanisms of aversion (Wise et al. 1970; Tye et al. 1977; Deakin 1983).”
Background
Research works printed but not linked: 3
- Cooper SJ, Owen F, Chambers DR, Crow TJ, Johnson J, Poulter M (1986) Post-mortem neurochemical findings in suicide and depression: a study of the serotonergic system and imipramine binding in suicide victims. In: Deakin JFW (ed) The biology of depression. Gaskell, London, pp 53–70
- Deakin JFW (1989) Role of 5HT receptor subtypes in depression and anxiety. In: Archer T, Bevan P, Cools A (eds) Behavioural pharmacology of 5HT. Lawrence Erlbaum, New York (in press)
- Guimaraes FS, Hellewell J, Wang M, Deakin JFW (1990) Sex difference in aversive classical conditioning and responsiveness to anxiolytic drugs in humans. Br J Clin Pharmacol (in press)
Cited by
Discriminative and affective touch: Sensing and feeling.
McGlone, F., Wessberg, J., & Olausson, H. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.001 · Cited by 1,112
“These findings suggest that dynamic tactile allodynia is associated with a reduced CT hedonic touch processing; however, whether CT signaling contributes to the allodynic experience, or reduces the hyperalgesia, remains an open question (Delfini et al., 2013; see also Nagi et al., 2011).”
Background5-HT and mechanisms of defence
Deakin, J. F. W., & Graeff, F. G. (1991) · Journal of Psychopharmacology · doi:10.1177/026988119100500414 · Cited by 1,010
Self-citationRole of 5-HT in stress, anxiety, and depression
Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984
Self-citationEstrogen–serotonin interactions: implications for affective regulation
Rubinow, D. R., Schmidt, P. J., & Roca, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00162-0 · Cited by 505
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
van Praag, H. M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.031 · Cited by 377
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
Dinan, T. G. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.3.365 · Cited by 339
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
“and growth hormone responses in depressives compared with controls (Cowen and Charig, 1987; Deakin et al. 1990; Price et al., 1991, Kapitany et al., 1999).”
BackgroundSelf-citationThe neuroendocrinology of depression and chronic stress
Checkley, S. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011570 · Cited by 322
Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function
Dinan, T. G. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00066-5 · Cited by 303
Delgado, P. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110025005 · Cited by 289
Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
Cleare, A. J., Bearn, J., Allain, T., McGregor, A., Wessely, S., Murray, R. M., & O'Keane, V. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00026-j · Cited by 255
Kramer, M. S., Winokur, A., Kelsey, J., Preskorn, S. H., Rothschild, A. J., Snavely, D., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 256
“Subsequent literature (eg Arora and Meltzer, 1989; Deakin et al, 1990; Delgado et al, 1989; Maes et al, 1990; Meltzer and Lowy, 1987; M ller et al, 1990; Sarrias et al, 1987; Upadhyaya et al, 1991; Young et al, 1985) suggested that serotonergic mechanisms may in part underlie vulnerability to major…”
BackgroundEllenbogen, M. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00056-5 · Cited by 242
Van Praag, H. M. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030018 · Cited by 184
“These data, too, suggest a defect in the synthesis of 5-HT. Direct measurement of 5-HT synthetic capacity is presently possible by positron emission tomography (PET), measuring the trapping of the tracer [a-11C] methyl-L-tryptophan (a-MTrp) into the synthesis of 5-HT. a-MTrp is a synthetic analog of L-tryptophan.”
InfluentialCools, R., Robinson, O. J., & Sahakian, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301598 · Cited by 172
“…observation that serotonergic neurotransmission is implicated in a range of mood and anxiety disorders (Young et al , 1985; Anderson et al , 1990; Deakin et al , 1990; Blier and de Montigny, 1999) that are characterized by enhanced anticipation of, and sensitivity to threat-related stimuli,…”
Strickland, P. L., Deakin, J. F. W., Percival, C., Dixon, J., Gater, R. A., & Goldberg, D. P. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.2.168 · Cited by 169
Self-citationCorticosteroid–serotonin interactions in depression: a review of the human evidence
Porter, R. J., Gallagher, P., Watson, S., & Young, A. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1774-1 · Cited by 169
“Deakin et al. (1990) found that increased baseline cortisol levels were associated with reduced PRL responses, but there was no association with GH responses.”
Neuroendocrine probes of serotonergic function: A critical review
Yatham, L. N., & Steiner, M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90696-z · Cited by 164
Fortnightly review: Stress, the brain, and mental illness
Herbert, J. (1997) · BMJ · doi:10.1136/bmj.315.7107.530 · Cited by 146
Joca, S. R. L., Ferreira, F. R., & Guimarães, F. S. (2007) · Stress · doi:10.1080/10253890701223130 · Cited by 137
“2000) and show a marked attenuation of prolactin release in response to intravenous tryptophan (Deakin et al. 1990).”
BackgroundMethodBlunted Serotonergic Responsivity in Depressed Inpatients
Mann, J. J., McBride, P. A., Malone, K. M., DeMeo, M., & Keilp, J. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00016-7 · Cited by 157
Mutant mouse models of depression: Candidate genes and current mouse lines
Urani, A., Chourbaji, S., & Gass, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.020 · Cited by 144
Hippocampal 5-HT receptors and consolidation of stressful memories
Guimarães, F. S., Bel, E. A. D., Padovan, C. M., Netto, S. M., & Titze‐de‐Almeida, R. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90098-b · Cited by 125
A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
Deakin, J. F. W. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700308 · Cited by 112
Self-citation5-HT1A Receptor binding sites in post-mortem brain samples from depressed suicides and controls
Lowther, S., Paermentier, F. D., Cheetham, S. C., Crompton, M. R., Katona, C., & Horton, R. W. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)01413-9 · Cited by 111
Papp, M., Klimek, V., & Willner, P. (1994) · Psychopharmacology · doi:10.1007/bf02244853 · Cited by 109
Joca, S. R. L., Padovan, C. M., & Guimarães, F. S. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02943-3 · Cited by 109
The premenstrual syndrome – a reappraisal of the concept and the evidence
Bancroft, J. (1993) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100001272 · Cited by 103
5-HT1A Receptor Sensitivity in Major Depression: A Neuroendocrine Study with Buspirone
Cowen, P. J., Power, A. C., Ware, C. J., & Anderson, I. M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.3.372 · Cited by 103
Hippocampal Neurogenesis, Depressive Disorders, and Antidepressant Therapy
Paizanis, E., Hamon, M., & Lanfumey, L. (2007) · Neural Plasticity · doi:10.1155/2007/73754 · Cited by 94
Agren, H., Reibring, L., Hartvig, P., Tedroff, J., Bjurling, P., Hörnfeldt, K., Andersson, Y., Lundqvist, H., & Langström, B. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05574.x · Cited by 96
Serotonin Receptor Subtypes: Implications for Psychopharmacology
Cowen, P. J. (1991) · British Journal of Psychiatry · doi:10.1192/s0007125000296190 · Cited by 97
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1518 · Cited by 88
van Praag, H. M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02923-x · Cited by 87
Baumann, M. H., & Rothman, R. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00123-1 · Cited by 91
Holz, N., Boecker, R., Buchmann, A. F., Blomeyer, D., Baumeister, S., Hohmann, S., Jennen-Steinmetz, C., Wolf, I., Rietschel, M., Witt, S. H., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhu249 · Cited by 76
“Crucially, moreover, serotonin stimulates cortisol secretion (Deakin et al. 1990; Price et al. 1998), with MAOA-L carriers showing increased hypothalamus-pituitary axis reactivity after stress”
5-HT-HPA Interactions in Two Models of Transgenic Mice Relevant to Major Depression
Lanfumey, L., la Cour, C. M., Froger, N., & Hamon, M. (2000) · Neurochemical Research · doi:10.1023/a:1007683810230 · Cited by 82
“It has been suggested that tonic hypersecretion of glucocorticoids in patients suffering from major depression may down regulate central 5-HT 1A receptors and decrease 5-HT 1A receptor-mediated responses (32, 33).”
BackgroundRyan, N. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110007001 · Cited by 81
Cleare, A. J. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00144-3 · Cited by 81
Anxiety/aggression - driven depression
van Praag, H. M. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00151-8 · Cited by 85
Maes, M. H. J., Verkerk, R. M., Vandoolaeghe, E., Hunsel, F. V., Neels, H. M., Wauters, A., Demedts, P., & Scharpé, S. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03033069 · Cited by 80
5 -HT, antidepressant drugs and the psychosocial origins of depression
Deakin, J. F. W. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000106 · Cited by 71
Self-citationSakai, Y., Nishikawa, M., Leyton, M., Benkelfat, C., Young, S. N., & Dikšić, M. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.08.004 · Cited by 74
The citalopram challenge test in patients with major depression and in healthy controls
Kapitany, T., Schindl, M., Schindler, S. D., Heßelmann, B., Füreder, T., Barnas, C., Sieghart, W., & Kasper, S. F. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00082-7 · Cited by 69
Sobczak, S., Honig, A., Van Duinen, M., & Riedel, W. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01217.x · Cited by 69
van Praag, H. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)84782-1 · Cited by 69
Meijer, O. C., van Oosten, R. V., & de Kloet, E. R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00008-0 · Cited by 73
Depression and antisocial personality disorder: two contrasting disorders of 5HT function
Deakin, J. F. W. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6020-6_5 · Cited by 65
Self-citationThe origins of ‘5-HT and mechanisms of defence’ by Deakin and Graeff: A personal perspective
Deakin, J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113503508 · Cited by 59
Self-citationDecreased 5-HT-Mediated Prolactin Release in Major Depression
Anderson, I. M., Ware, C., Davis, J. M., & Cowen, P. J. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.160.3.372 · Cited by 63
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Nicholas, L. M., Dawkins, K., & Golden, R. N. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70009-5 · Cited by 59
Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.
Power, A. C., & Cowen, P. (1992) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(92)90010-w · Cited by 62
The role of serotonin in depression and anxiety
Deakin, J. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80015-1 · Cited by 56
Self-citationThe Neurobiology of Tryptophan Depletion in Depression: Effects of Intravenous Tryptophan Infusion
Price, L. H., Malison, R. T., McDougle, C. J., Pelton, G. H., & Heninger, G. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00284-9 · Cited by 57
Hormone responses to fenfluramine and placebo challenge in endogenous depression
Lichtenberg, P., Shapira, B., Gillon, D., Kindler, S., Cooper, T. B., Newman, M. E., & Lerer, B. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90128-p · Cited by 54
D-fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment
O’Keane, V., McLoughlin, D. M., & Dinan, T. G. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90009-u · Cited by 59
O'Hare, T., & Creed, F. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.6.799 · Cited by 56
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1626 · Cited by 54
Ferretti, C., Blengio, M., Gamalero, S. R., & Ghi, P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00172-h · Cited by 51
Pindolol decreases prolactin and growth hormone responses to intravenousL-tryptophan
Smith, C. E., Ware, C., & Cowen, P. J. (1991) · Psychopharmacology · doi:10.1007/bf02244090 · Cited by 51
Suzuki, K., Kusumi, I., Sasaki, Y., & Koyama, T. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00221-4 · Cited by 50
Cowen, P., McCance, S., Ware, C., Cohen, P. R., Chalmers, J. S., & Julier, D. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.3.341 · Cited by 52
The 5-HT receptor ? G-protein ? effector system complex in depression I. Effect of glucocorticoids
Lesch, K., & Lerer, B. (1991) · Journal of Neural Transmission · doi:10.1007/bf01249105 · Cited by 52
Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin
Kawa, L., Arborelius, U. P., Yoshitake, T., Kehr, J., Hökfelt, T. G. M., Risling, M., & Agoston, D. V. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3669 · Cited by 51
Anderson, I., Parry-billings, M., Newsholme, E., Poortmans, J., & Cowen, P. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90143-v · Cited by 54
HPA axis function in male caregivers: Effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR)
Brummett, B. H., Boyle, S. H., Siegler, I. C., Kuhn, C. M., Surwit, R. S., Garrett, M. E., Collins, A., Ashley-Koch, A., & Williams, R. B. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.06.004 · Cited by 45
“More specifically, because it is known that increased CNS serotonin function (Deakin et al., 1990) stimulates the HPA axis to secrete cortisol; and furthermore, that acute stress leads to an increase in CNS 5-HT in animal models (Beekman et al., 2005; Samad et al., 2006; Linthorst and Reul, 2008),…”
BackgroundBiological markers of depression
Cowen, P. J., & Wood, A. J. (1991) · Psychological Medicine · doi:10.1017/s0033291700029834 · Cited by 46
The elevation of plasma β-endorphin levels in major depression
Goodwin, G. M., Austin, M., Curran, S., Ross, M. C., Murray, C. L., Prentice, N. P., Ebmeier, K. P., Bennie, J., Carroll, S., Dick, H., et al. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90018-f · Cited by 48
Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress
Richell, R. A., Deakin, J. F. W., & Anderson, I. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.010 · Cited by 43
Self-citationHigh-resolution imaging of brain 5-HT1B receptors in the rhesus monkey using [11C]P943
Nabulsi, N., Huang, Y., Weinzimmer, D., Ropchan, J., Frost, J. J., McCarthy, T., Carson, R. E., & Ding, Y.-S. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.10.007 · Cited by 42
Mood state moderates the role of serotonin in cognitive biases
Robinson, O., Cools, R., Crockett, M., & Sahakian, B. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108100257 · Cited by 38
Upadhyaya, A. K., Pennell, I., Cowen, P. J., & Deakin, J. F. W. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90042-q · Cited by 40
Self-citationThe Interpeduncular-Ventral Hippocampus Pathway Mediates Active Stress Coping and Natural Reward
Sherafat, Y., Bautista, M. R., Fowler, J. P., Chen, E., Ahmed, A., & Fowler, C. D. (2020) · eNeuro · doi:10.1523/eneuro.0191-20.2020 · Cited by 36
“Indeed, patients at risk of stress coping maladaptive responses, such as that found in depression, are found to have persistent abnormalities in brain serotonin mechanisms (Deakin et al., 1990; Cowen, 2008).”
BackgroundHaider, S., Saleem, S., Tabassum, S., Khaliq, S., Shamim, S., Batool, Z., Parveen, T., Inam, Q.-U.-A., & Haleem, D. J. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9374-y · Cited by 35
“Depression relates to two processes one is an endogenous mechanism indicated by reduced growth hormone and other process is impairment in serotonin (5-HT) system indicated by blunted prolactin responses and perhaps caused by raised cortisol or reduced tryptophan (TRP) concentration (Deakinet al.…”
BackgroundElevated prolactin responses to l-tryptophan infusion in medication-free depressed patients
Porter, R., Gallagher, P., Watson, S., Smith, M. S., & Young, A. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1475-1 · Cited by 36
“Using the technique of l-tryptophan (l-TRP) infusion, studies have demonstrated attenuated prolactin (PRL) and growth hormone (GH) responses in patients with major depression, indicative of an impairment in postsynaptic 5HT1A receptor function (Heninger et al. 1984; Koyama and Meltzer 1986; Cowen and Charig 1987; Deak…”
BackgroundMethodInfluentialLund, A., Mjellem, N., & Hole, K. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90156-j · Cited by 34
Hennig, J., Toll, C., Schonlau, P., Rohrmann, S., & Netter, P. (2000) · Neuropsychobiology · doi:10.1159/000026631 · Cited by 32
Jolly, D. C., Richards, J. B., & Seiden, L. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00014-6 · Cited by 31
SUMNER, B. E. H., Rosie, R., & Fink, G. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90041-y · Cited by 31
EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans
McAllister-Williams, H., & Massey, A. E. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1339-0 · Cited by 34
“…response to l-tryptophan have shown that depressed patients have an impairment in postsynaptic 5-HT1A receptor function (Charney et al. 1984; Koyama and Meltzer 1986; Cowen and Charig 1987; Deakin et al. 1990; Price et al. 1991), with this impairment being state dependent (Upadhyaya et al. 1991).”
BackgroundSerotonin and gender-specific psychiatric disorders
Steiner, M., Lepage, P., & Dunn, E. J. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709069200 · Cited by 30
Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
Cleare, A. J., Bearn, J., McGregor, A., Allain, T. J., Wessely, S. C., Murray, R. M., & O’Keane, V. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)94634-9 · Cited by 30
Herman, A. I., Conner, T. S., Anton, R. F., Gelernter, J. E., Kranzler, H. R., & Covault, J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00197.x · Cited by 34
“Although sex differences in serotonergic function are not well understood, multiple studies have shown such differences (Delgado et al. 1989; Deakin et al. 1990; Manuck et al. 1999; Soloff et al. 2003).”
Backgroundvan Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 33
The neuroendocrine response to d-fenfluramine in women with premenstrual depression
Bancroft, J., & Cook, A. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00060-7 · Cited by 29
McQuade, R., Leitch, M. M., Gartside, S. E., & Young, A. H. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047276 · Cited by 24
Tomiyoshi, R., Kamei, K., Muraoka, S., Muneoka, K. T., & Takigawa, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00171-1 · Cited by 23
Corticosteroid Receptor Transgenic Mice: Models for Depression?
Urani, A., & Gass, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.037 · Cited by 26
Anxiolytic-like effect of group housing on stress-induced behavior in rats
Andrade, C. S., & Guimarães, F. S. (2003) · Depression and Anxiety · doi:10.1002/da.10124 · Cited by 22
“One factor that could increase vulnerability to depression is chronic psychosocial difficulty [Brown and Harris, 1986], perhaps by raising basal cortisol concentrations [Deakin et al., 1990] and impairing 5HT1A-mediated neurotransmission [Deakin et al., 1992; Graeff et al., 1996].”
BackgroundDepression: an inability to adapt to one's perceived life distress?
Bedi, R. P. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00196-7 · Cited by 20
The Neuroendocrinology of Affective Disorders
Rubín, R. T., Dinan, T. G., & Scott, L. V. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50099-8 · Cited by 21
Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients
Bhagwagar, Z., Hafizi, S., & Cowen, P. J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00467-0 · Cited by 19
Cappiello, A. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00057-7 · Cited by 18
Farisse, J., Boulenguez, P., Sémont, A., Hery, F., Barden, N., Faudon, M., & Héry, M. (1999) · Neuroendocrinology · doi:10.1159/000054503 · Cited by 17
Endocrine and amine responses to D,L-fenfluramine in normal subjects
Mitchell, P. B., & Smythe, G. A. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90083-2 · Cited by 17
5-HT Receptor Mechanisms in Human Anxiety
Deakin, J. F. W., Guimarães, F. S., Wang, M., Hellewell, J. S. E., & Hensman, R. (1991) · doi:10.1007/978-1-349-11847-2_6 · Cited by 14
Self-citationGhaziuddin, N., King, C. A., Welch, K. B., Zaccagnini, J., Weidmer-Mikhail, E., Mellow, A. M., Ghaziuddin, M., & Greden, J. F. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00163-3 · Cited by 12
The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol
Mulder, R., Porter, R., & Joyce, P. R. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001711 · Cited by 11
Porter, R., Gallagher, P., Watson, S., Lunn, B. S., & Young, A. H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1094-2 · Cited by 11
Metadata
- Authors
- Deakin, J. F. W., Pennell, I., Upadhyaya, A. J., & Lofthouse, R.
- Affiliations
- Northwick Park Hospital (GB)
- ORCID
- Deakin, J. F. W.
- Venue
- Psychopharmacology
- Published
- 1990-05
- Volume
- 101
- Issue
- 1
- Pages
- 85-92
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1993015131
- Cited by
- 132
- References
- 45
- Citations by year
- 2020: 1 · 2015: 1 · 2014: 3 · 2013: 2
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, serotonin, growth hormone, prolactin, cortisol, neuroendocrine response, psychosocial stress, endogenous depression, major depressive disorder
- MeSH terms
- Adolescent, Adult, Depressive Disorder, Female, Humans, Hydrocortisone, Male, Prolactin, Serotonin, Growth Hormone, Tryptophan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.